Physician profile
James A Roberts
NPI 1043242787
$1,097.80
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $620 · 2020: $477.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $250.47 | 2019-2020 | |
| Novo Nordisk INC | $143.49 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $128.19 | 2019-2020 | |
| Pfizer INC. | $97.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $79.04 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $63.68 | 2019 | |
| Ucb, INC. | $55.11 | 2019 | |
| Amgen INC. | $49.98 | 2019-2020 | |
| Lilly USA, LLC | $40.00 | 2019-2020 | |
| Amarin Pharma, INC. | $35.67 | 2020 | |
| Arbor Pharmaceuticals, INC. | $27.44 | 2019-2020 | |
| Abbott Laboratories | $22.21 | 2019 | |
| Glaxosmithkline, LLC. | $20.46 | 2020 | |
| Allergan, INC. | $18.57 | 2020 | |
| Avion Pharmaceuticals | $18.27 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $18.13 | 2020 | |
| Hikma Pharmaceuticals USA | $16.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.66 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.